Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celldex Therapeutics Inc (NASDAQ:CLDX)

3.43
Delayed Data
As of Aug 30
 -0.05 / -1.44%
Today’s Change
2.96
Today|||52-Week Range
18.62
-78.12%
Year-to-Date
3 Reasons Celldex Therapeutics, Inc. Stock Could Fall
Aug 26 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close3.48
Today’s open3.47
Day’s range3.36 - 3.53
Volume1,481,141
Average volume (3 months)2,556,721
Market cap$349.9M
Dividend yield--
Data as of 4:00pm ET, 08/30/2016

Growth & Valuation

Earnings growth (last year)+0.76%
Earnings growth (this year)-2.10%
Earnings growth (next 5 years)--
Revenue growth (last year)+52.82%
P/E ratioNM
Price/Sales277.69
Price/Book1.18

Competitors

 Today’s
change
Today’s
% change
TRIBTrinity Biotech PLC-0.05-0.37%
LNTHLantheus Holdings In...-0.11-1.13%
IMMUImmunomedics Inc+0.05+1.85%
OXFDOxford Immunotec Glo...+0.07+0.68%
Data as of 4:00pm ET, 08/30/2016

Financials

Next reporting dateOctober 27, 2016
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$5.5M
Annual profit (last year)-$127.2M
Net profit margin-2,321.11%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Anthony S. Marucci
CFO, Secretary, Treasurer &
Senior Vice President
Avery W. Catlin
Corporate headquarters
Hampton, New Jersey

Forecasts

Search for Jobs